Ramaswamy, Shankar;Lewis, Bryan M;Axovant Sciences GmbH;Piscitelli, Stephen Clement;Kishnani, Kunal;Friedhoff, Lawrence Tim;Rhodes, Melissa;Ramaswamy, Geetha
发明人:
Friedhoff, Lawrence Tim,Kishnani, Kunal,Lewis, Bryan M,Piscitelli, Stephen Clement,Ramaswamy, Geetha,Ramaswamy, Shankar,Rhodes, Melissa
申请号：
NO20171934
公开号：
NO20171934A1
申请日:
2017.12.05
申请国别(地区):
NO
年份:
2017
代理人:
摘要：
The present application relates to new uses of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or pharmaceutically acceptable salts, hydrates, solvates, or polymorphs, thereof, and to the combination of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or pharmaceutically acceptable salts, hydrates, solvates, or polymorphs, thereof, with other therapeutic agents for the treatment of a neurodegenerative disease.The present application relates to new uses of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-lyl- quinoline or pharmaceutically acceptable salts, hydrates, solvates, or polymorphs, thereof, and to the combination of 5-HT6 receptor antagonists, specifically 3-phenylsulfonyl-8-piperazinyl-lyl- quinoline or pharmaceutically acceptable salts, hydrates, solvates, or polymorphs, thereof, with other therapeutic agents for the treatment of a neurodegenerative disease.
